Feastaw
@feastaw
Parataxis is buying a Korean biotech firm, Bridge Bio. They’ll use it to launch a Bitcoin treasury platform there. The goal? More institutional BTC access, even with strict rules. Bitcoin’s the key player here.
0 reply
0 recast
0 reaction